NTHL1 and breast cancer: It has recently been shown that carriers of bi-allelic loss-of-function (LoF) variants in NTHL1 are predisposed to colorectal adenomatous polyposis and colorectal cancer1, and to a multi-tumor syndrome that includes a high incidence of breast cancer in female carriers2–5.